Dr. Marisa Carly Mizus, MD

Dr. Mizus practices at Falls Medical Specialists in Lutherville, Maryland.

Dr. Mizus' NPI, 1558654418, was assigned on May 25, 2011. Dr. Mizus graduated from New York University School of Medicine in 2011. Dr. Mizus' Maryland license number on file is D83503.

Dr. Mizus' primary practice is Falls Medical Specialists, at 10753 Falls Rd Ste 225 Suite 225, Lutherville, MD 21093. The practice phone is (410) 583-2848.

Dr. Mizus' primary practice is Falls Medical Specialists in Lutherville, Maryland. Dr. Mizus is also affiliated with The Johns Hopkins Hospital. The medical group on file is Falls Medical Specialists. Dmand AI also links Dr. Mizus to 3 more medical groups and 2 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mizus practices, 4 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Mizus' primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Mizus is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mizus' licenses on file in 2 states: Maryland and Pennsylvania.

CMS data shows 25,602 Medicare services from Dr. Mizus across 8 procedure codes in 2024, for 290 Medicare patients. Medicare paid $172,811 for them. Every service was in an office.

CMS counts 290 Medicare patients who saw Dr. Mizus in 2024. The largest group is 65 to 74, with 130 patients. 75% of them have arthritis, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.33, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mizus' median patient age at 63, with 78% women.

In 2024, Dr. Mizus wrote 914 Medicare Part D claims for 258 patients. 82% of them were for generic drugs. CMS names the drug for 763 of them, across 18 drugs with 11 or more claims each, at $841,070 in total drug cost. In 2023, CMS named 580 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 70 out of 100 for Dr. Mizus for performance year 2024, reported as part of a group. CMS lists Dr. Mizus as offering telehealth.

Dmand AI links 8 papers to Dr. Mizus, published from 2016 to 2020. 2019 was the busiest year, with 2. Dr. Mizus' most frequent co-authors are Lee R. Goldberg, MD, Michelle A. Petri, MD and Eleni Tiniakou, MD.

CMS Open Payments shows 322 general payments to Dr. Mizus from 26 drug and device companies from 2018 to 2025. Speaker and faculty fees make up the largest share, 69% of the total. Abbvie Inc. paid the most, $82,135.

Dmand AI lists 6 awards for Dr. Mizus, most recently Gordon Memorial Fund in 2019.

Dr. Mizus graduated from New York University School of Medicine in 2011. Dr. Mizus is a member of ACC, ACR, Association of Women in Rheumatology and Maryland Society for Rheumatic Diseases.

Dr. Mizus is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and CareFirst BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.